[go: up one dir, main page]

NO20075385L - 7-aminoalkylidenyl-heterocykliske kinoloner og naftyridoner - Google Patents

7-aminoalkylidenyl-heterocykliske kinoloner og naftyridoner

Info

Publication number
NO20075385L
NO20075385L NO20075385A NO20075385A NO20075385L NO 20075385 L NO20075385 L NO 20075385L NO 20075385 A NO20075385 A NO 20075385A NO 20075385 A NO20075385 A NO 20075385A NO 20075385 L NO20075385 L NO 20075385L
Authority
NO
Norway
Prior art keywords
aminoalkylidenyl
naphthyridones
quinolones
heterocyclic
heterocyclic quinolones
Prior art date
Application number
NO20075385A
Other languages
English (en)
Other versions
NO340833B1 (no
Inventor
Mark J Macielag
Iii Eugene B Grant
Steven David Paget
Michele Ann Weidner-Wells
Xiaoqing Xu
Xiaodong Xu
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20075385L publication Critical patent/NO20075385L/no
Publication of NO340833B1 publication Critical patent/NO340833B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Foreliggende oppfinnelse angår forbindelser som har strukturen i henhold til formel (I), hvor n, m, z, R, R2, R3, R4, R5, R6, A, E, X, Y, a og b er som definert i beskrivelsen; eller en optisk isomer, diastereomer, enantiomer, farmasøytisk akseptabelt salt, hydrat eller prodrug derav.
NO20075385A 2005-03-21 2007-10-22 7-aminoalkylidenylheterocykliske kinolon- og naftyridon-forbindelser og farmasøytiske sammensetninger NO340833B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/084,987 US7732612B2 (en) 2004-09-09 2005-03-21 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
PCT/US2006/003657 WO2006101603A1 (en) 2005-03-21 2006-02-02 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones

Publications (2)

Publication Number Publication Date
NO20075385L true NO20075385L (no) 2007-12-14
NO340833B1 NO340833B1 (no) 2017-06-26

Family

ID=36648281

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075385A NO340833B1 (no) 2005-03-21 2007-10-22 7-aminoalkylidenylheterocykliske kinolon- og naftyridon-forbindelser og farmasøytiske sammensetninger

Country Status (22)

Country Link
US (1) US7732612B2 (no)
EP (1) EP1861401B1 (no)
JP (1) JP4977684B2 (no)
KR (1) KR101323665B1 (no)
CN (1) CN101248070B (no)
AR (1) AR053342A1 (no)
AU (1) AU2006227984A1 (no)
BR (1) BRPI0609426B8 (no)
CA (1) CA2602140C (no)
CR (1) CR9458A (no)
DK (1) DK1861401T3 (no)
EA (1) EA014554B1 (no)
ES (1) ES2561834T3 (no)
IL (1) IL186041A (no)
MX (1) MX2007011774A (no)
MY (1) MY147638A (no)
NO (1) NO340833B1 (no)
NZ (1) NZ561651A (no)
TW (1) TWI444380B (no)
UA (1) UA93672C2 (no)
WO (1) WO2006101603A1 (no)
ZA (1) ZA200708868B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7913302B2 (en) * 2004-05-02 2011-03-22 Markmonitor, Inc. Advanced responses to online fraud
US20090156577A1 (en) * 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
WO2007081597A2 (en) * 2005-10-21 2007-07-19 Glaxo Group Limited Peri condensed tricyclic compounds useful as antibacterial agents
EP1963324B1 (en) 2005-12-22 2010-04-21 Glaxo Group Limited Heterocyclic compounds, their preparation and their use as antibacterials
DK2001862T3 (da) * 2006-03-28 2011-08-08 Warner Chilcott Co Llc Malatsalte og polymorfe af (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyklopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolincarboxylsyre
BRPI0709220A2 (pt) * 2006-03-28 2011-07-12 Procter & Gamble processo de acoplamento para preparo de intermediários de quinolona
ES2524457T3 (es) 2008-05-29 2014-12-09 Bluestar Silicones France Artículo que presenta propiedades antiincrustantes, y destinado a ser utilizado en aplicaciones acuáticas, en particular marinas
JO3611B1 (ar) 2011-08-10 2020-08-27 Janssen Sciences Ireland Uc سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم
ES2881681T3 (es) 2011-08-10 2021-11-30 Janssen Sciences Ireland Unlimited Co 3,4-Dihidro-1H-[1,8]naftiridinonas sustituidas con piperidinilo antibacterianas
KR101774044B1 (ko) 2011-09-30 2017-09-01 얀센 파마슈티카 엔.브이. 2-[(2ｅ)-2-플루오로-2-(3-피페리디닐리덴)에틸]-1ｈ-이소인돌-1,3(2h)-디온을 제조하기 위한 개선된 방법
WO2014087292A1 (en) * 2012-12-04 2014-06-12 Mankind Research Centre An improved process for the preparation of moxifloxacin hydrochloride
WO2016079757A2 (en) * 2014-11-19 2016-05-26 Symed Labs Limited Novel processes for preparing 5-hydroxymethyl-oxazolidin-2-one derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1019114B (zh) 1986-03-31 1992-11-18 三共株式会社 喹啉-3-羟酸衍生物的制备方法
JPH0262875A (ja) * 1988-05-23 1990-03-02 Wakunaga Pharmaceut Co Ltd 新規イソインドリン誘導体
CA1332605C (en) * 1988-10-03 1994-10-18 Yasuhiro Nishitani Pyridonecarboxylic acids
US5580872A (en) * 1990-05-02 1996-12-03 Abbott Laboratories Quinolizinone type compounds
FR2692577B1 (fr) 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
NO304832B1 (no) * 1992-05-27 1999-02-22 Ube Industries Aminokinolonderivater samt middel mot HIV
JPH07300472A (ja) * 1992-12-28 1995-11-14 Korea Res Inst Chem Technol 新規キノロンカルボン酸誘導体およびその製造方法
JPH06263754A (ja) 1993-03-12 1994-09-20 Hokuriku Seiyaku Co Ltd ７−アミノピロリジニルキノリン−３−カルボン酸誘導体
EP1015445B1 (en) 1997-09-15 2009-02-25 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
US6964966B2 (en) 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6878713B2 (en) 2001-04-25 2005-04-12 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
SI1675852T1 (sl) * 2003-09-22 2009-06-30 Janssen Pharmaceutica Nv 7-amino alkilidenil-heterociklični kinoloni in naftiridoni

Also Published As

Publication number Publication date
MX2007011774A (es) 2008-03-10
KR20070113304A (ko) 2007-11-28
BRPI0609426A2 (pt) 2010-04-06
NO340833B1 (no) 2017-06-26
TW200700418A (en) 2007-01-01
CA2602140C (en) 2015-04-14
CR9458A (es) 2008-09-09
AU2006227984A1 (en) 2006-09-28
MY147638A (en) 2012-12-31
ES2561834T3 (es) 2016-03-01
BRPI0609426B8 (pt) 2021-05-25
DK1861401T3 (en) 2015-12-07
EP1861401A1 (en) 2007-12-05
CN101248070A (zh) 2008-08-20
CN101248070B (zh) 2011-12-14
BRPI0609426B1 (pt) 2020-09-24
KR101323665B1 (ko) 2013-10-31
AR053342A1 (es) 2007-05-02
UA93672C2 (en) 2011-03-10
IL186041A0 (en) 2008-02-09
JP2008538110A (ja) 2008-10-09
US7732612B2 (en) 2010-06-08
ZA200708868B (en) 2009-01-28
EA200702039A1 (ru) 2008-02-28
WO2006101603A1 (en) 2006-09-28
IL186041A (en) 2016-05-31
JP4977684B2 (ja) 2012-07-18
NZ561651A (en) 2011-09-30
TWI444380B (zh) 2014-07-11
US20060052359A1 (en) 2006-03-09
EA014554B1 (ru) 2010-12-30
EP1861401B1 (en) 2015-11-18
CA2602140A1 (en) 2006-09-28

Similar Documents

Publication Publication Date Title
NO20075385L (no) 7-aminoalkylidenyl-heterocykliske kinoloner og naftyridoner
WO2007016392A3 (en) Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
PE20081530A1 (es) Nuevos compuestos 617
NO20084583L (no) Makrosykliske kinase-inhibitorer
WO2005074603A3 (en) Aminobenzoxazoles as therapeutic agents
CY1109424T1 (el) 7-αμινο αλκυλιδενυλ-ετεροκυκλικες κινολονες και ναφθυριδονες
WO2008005368A3 (en) Piperazines as p2x7 antagonists
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
NO20081930L (no) Oksazolforbindelser og farmasoytiske blandinger
EA201000395A1 (ru) Фунгицидные производные 2-алкилтио-2-хинолинилоксиацетамида
SE0400284D0 (sv) Novel compounds
NO20060847L (no) Substituert 2-aminotetralin til behandling av depresjon
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
NO20076145L (no) Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav
ATE360045T1 (de) Polycarbonatzusammensetzungen
EA200970372A1 (ru) Ингибитор развития болезни альцгеймера, содержащий гетероциклическое соединение
WO2006113509A3 (en) Quinobenzoxazine analogs and methods of using thereof
EA200801199A1 (ru) Ингибиторы киназы
DK1954690T3 (da) Benzamidforbindelser, der er anvendelige som inhibitorer af histondeacetylase
WO2010056633A3 (en) 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
DK2046754T3 (da) Fremgangsmåde til fremstilling af alkylanilider ud fra halogenbenzenderivater
MA32834B1 (fr) 3-aminocyclopentanecarboxamides servant de modulateurs de recepteurs de chimiokines
ATE417849T1 (de) Pyrazoloä4,3-düpyrimidine
DK1301475T3 (da) Arylsulfonamider, som serotoninantagonist til behandling af obesitet
EA200600760A1 (ru) Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees